-
IMPACT OF BASELINE COMORBIDITIES AND COMBINATIONS OF COMORBIDITIES AMONG PEOPLE WITH TYPE 2 DIABETES ON HEALTH CARE RESOURCE UTILISATION IN THE UK
Aug 11, 2026, 17:16 PM -
FROM DATA TO CLINICAL TRANSFORMATION: SELF-SERVICE ANALYTICS AS A CATALYST FOR NURSING-LED REDUCTION IN CHEMOTHERAPY TREATMENT WAIT TIMES
Aug 11, 2026, 17:16 PM -
COMPARATIVE EVALUATION OF PROCEDURE-BASED TARIFFS IN THE SOCIAL SECURITY INSTITUTION (SGK) EK-2C REIMBURSEMENT LIST AND THE MINISTRY OF HEALTH PUBLIC HEALTHCARE SERVICES TARIFF (SHFT) IN TURKIYE
Aug 11, 2026, 17:16 PM -
MODERNIZING HYPERTENSION ECONOMIC MODELS: INCORPORATING PROGNOSTIC RISK MARKERS AND MULTIFACETED TREATMENT EFFECTS WITHIN THE BAX-HTN MODEL
Aug 11, 2026, 17:16 PM -
CURRENT AND FUTURE ADOPTION OF ARTIFICIAL INTELLIGENCE BY EUROPEAN PAYERS
Aug 11, 2026, 17:16 PM -
VITILIGO IN COLOMBIA (2021-2025): DEMOGRAPHIC PROFILE AND REGIONAL DISTRIBUTION FROM POPULATION-BASED ADMINISTRATIVE DATA (RIPS)
Aug 11, 2026, 17:16 PM -
CLOSING THE LOOP IN HOSPITAL-BASED HTA: FROM ASSESSMENT TO REAL-WORLD OUTCOMES OF ADJUVANT OSIMERTINIB
Aug 11, 2026, 17:16 PM -
EVALUATING THE COST-EFFECTIVENESS OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL (FF/UMEC/VI) COMPARED WITH OTHER AVAILABLE TRIPLE THERAPIES FOR THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE COPD IN SPAIN
Aug 11, 2026, 17:16 PM -
RESOURCE UTILIZATION ASSOCIATED WITH THE PROVISION OF DISCRETIONARY TREATMENT IN CRITICALLY ILL CHILDREN
Aug 11, 2026, 17:16 PM -
EFFICACY OF DUPILUMAB IN PATIENTS HOSPITALIZED DUE TO CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION: PHASE 4 MISSION TRIAL DESIGN
Aug 11, 2026, 17:16 PM -
PRECEDENT BY PRACTICE: HOW EARLY JOINT CLINICAL ASSESSMENTS QUIETLY SET EVIDENCE STANDARDS
Aug 11, 2026, 17:16 PM -
MECHANISM-OF-ACTION-BASED COST-EFFECTIVENESS ANALYSIS OF INNOVATIVE DRUGS FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS IN HONG KONG - A MARKOV MODEL WITH NETWORK META-ANALYSIS INPUTS
Aug 11, 2026, 17:16 PM -
ESTABLISHING THE VALUE OF HOSPITAL ELECTRONIC MEDICAL RECORD DATA IN THE HEALTH TECHNOLOGY ASSESSMENT AND REASSESSMENT PROCESS FOR ONCOLOGY: HEPATOCELLULAR CARCINOMA IN THE CHANG GUNG RESEARCH DATABASE AS A CASE STUDY
Aug 11, 2026, 17:16 PM -
IMPORTANT CONSIDERATIONS IN THE SELECTION OF AI TOOLS TO SUPPORT HEALTH ECONOMIC MODEL REPLICATION
Aug 11, 2026, 17:16 PM -
REAL-WORLD EVIDENCE ON THE DIRECT MEDICAL COSTS OF DIABETES-RELATED COMPLICATIONS AT A TERTIARY HOSPITAL IN RIYADH, SAUDI ARABIA: A RETROSPECTIVE COST-OF-ILLNESS STUDY
Aug 11, 2026, 17:16 PM -
ENHANCING KAP ASSESSMENT WITH EXPERIMENTAL VIGNETTES: MODELING HEALTHCARE PROFESSIONAL DECISION-MAKING IN OBESITY CARE
Aug 11, 2026, 17:16 PM -
CLINICAL BURDEN, SEASONALITY AND MOLECULAR EPIDEMIOLOGY OF RSV IN CHILDREN =5 YEARS IN MEXICO: A SYSTEMATIC REVIEW ACROSS PRE-PANDEMIC, PANDEMIC, AND POST-PANDEMIC PERIODS
Aug 11, 2026, 17:16 PM -
DEVELOPMENT OF A VALUE ASSESSMENT MODEL FOR SHARED CLINICIAN-PATIENT DECISION-MAKING ON ANTINEOPLASTIC AGENTS IN CHINA: A DELPHI STUDY
Aug 11, 2026, 17:16 PM -
SELECTION AND USE OF PRIMARY ENDPOINTS IN ONCO-HEMATOLOGY: A DISEASE-SPECIFIC ANALYSIS OF CLINICAL EVIDENCE TO SUPPORT REGULATORY AND REIMBURSEMENT DECISIONS.
Aug 11, 2026, 17:16 PM -
ALIGNING MANAGED ENTRY AGREEMENTS WITH VALUE-BASED HEALTHCARE: A CONCEPTUAL FRAMEWORK BASED ON THE EUROPEAN UNION VALUE-BASED HEALTHCARE PILLARS
Aug 11, 2026, 17:16 PM
